rs143754727
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_004287.5(GOSR2):c.148C>T(p.Arg50Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000647 in 1,611,544 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R50H) has been classified as Uncertain significance.
Frequency
Consequence
NM_004287.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GOSR2 | NM_004287.5 | c.148C>T | p.Arg50Cys | missense_variant | 3/6 | ENST00000640051.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GOSR2 | ENST00000640051.2 | c.148C>T | p.Arg50Cys | missense_variant | 3/6 | 1 | NM_004287.5 | P3 |
Frequencies
GnomAD3 genomes ? AF: 0.000559 AC: 85AN: 152126Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00123 AC: 308AN: 251404Hom.: 7 AF XY: 0.00109 AC XY: 148AN XY: 135876
GnomAD4 exome AF: 0.000656 AC: 957AN: 1459300Hom.: 11 Cov.: 28 AF XY: 0.000662 AC XY: 481AN XY: 726202
GnomAD4 genome ? AF: 0.000558 AC: 85AN: 152244Hom.: 1 Cov.: 32 AF XY: 0.000430 AC XY: 32AN XY: 74438
ClinVar
Submissions by phenotype
Progressive myoclonic epilepsy Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Nov 01, 2022 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 25, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 24, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at